Le Monde has published a very interesting article on the question of whether ageing can be considered a sickness by the FDA and if treating ageing could lead to a further increase in life expectancy thanks to molecules prescribed in the treatment of type 2 diabetics. This question echoes the trend that we analysed as part of the Ageing Well observation and our 2015 survey. Time magazine’s cover titled “This baby could live to be 142 years old”, Newsweek "Never say die" increasingly ask questions about the new limits of life and all the systemic changes that this can create. A trend to follow…